Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
about
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Real-World Outcomes in Fingoli ...... rom the 12-Month GOLEMS Study.
@en
Real-World Outcomes in Fingoli ...... rom the 12-Month GOLEMS Study.
@nl
type
label
Real-World Outcomes in Fingoli ...... rom the 12-Month GOLEMS Study.
@en
Real-World Outcomes in Fingoli ...... rom the 12-Month GOLEMS Study.
@nl
prefLabel
Real-World Outcomes in Fingoli ...... rom the 12-Month GOLEMS Study.
@en
Real-World Outcomes in Fingoli ...... rom the 12-Month GOLEMS Study.
@nl
P2093
P2860
P1476
Real-World Outcomes in Fingoli ...... rom the 12-Month GOLEMS Study.
@en
P2093
Pavla Kadlecová
Roman Kodým
Veronika Tichá
Zuzana Počíková
P2860
P304
P356
10.1007/S40261-016-0471-2
P577
2016-10-26T00:00:00Z